1. Home
  2. CPIX vs DMA Comparison

CPIX vs DMA Comparison

Compare CPIX & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • DMA
  • Stock Information
  • Founded
  • CPIX 1999
  • DMA 2011
  • Country
  • CPIX United States
  • DMA United States
  • Employees
  • CPIX N/A
  • DMA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • DMA Trusts Except Educational Religious and Charitable
  • Sector
  • CPIX Health Care
  • DMA Finance
  • Exchange
  • CPIX Nasdaq
  • DMA Nasdaq
  • Market Cap
  • CPIX 68.7M
  • DMA 72.0M
  • IPO Year
  • CPIX 2009
  • DMA N/A
  • Fundamental
  • Price
  • CPIX $4.70
  • DMA $8.40
  • Analyst Decision
  • CPIX
  • DMA
  • Analyst Count
  • CPIX 0
  • DMA 0
  • Target Price
  • CPIX N/A
  • DMA N/A
  • AVG Volume (30 Days)
  • CPIX 21.7K
  • DMA 34.6K
  • Earning Date
  • CPIX 05-06-2025
  • DMA 01-01-0001
  • Dividend Yield
  • CPIX N/A
  • DMA 2.04%
  • EPS Growth
  • CPIX N/A
  • DMA N/A
  • EPS
  • CPIX N/A
  • DMA N/A
  • Revenue
  • CPIX $41,083,299.00
  • DMA N/A
  • Revenue This Year
  • CPIX N/A
  • DMA N/A
  • Revenue Next Year
  • CPIX N/A
  • DMA N/A
  • P/E Ratio
  • CPIX N/A
  • DMA N/A
  • Revenue Growth
  • CPIX 5.82
  • DMA N/A
  • 52 Week Low
  • CPIX $1.04
  • DMA $4.78
  • 52 Week High
  • CPIX $7.25
  • DMA $8.00
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 52.45
  • DMA 54.92
  • Support Level
  • CPIX $4.32
  • DMA $8.25
  • Resistance Level
  • CPIX $4.86
  • DMA $8.54
  • Average True Range (ATR)
  • CPIX 0.34
  • DMA 0.19
  • MACD
  • CPIX -0.02
  • DMA 0.04
  • Stochastic Oscillator
  • CPIX 36.89
  • DMA 70.97

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.

Share on Social Networks: